Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization

The benefit of optimal medical therapy (OMT) on 5-year outcomes in patients with 3-vessel disease and/or left main disease after percutaneous coronary intervention or coronary artery bypass grafting (CABG) was demonstrated in the randomized SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial.The objective of this analysis is to assess the impact of the status of OMT at 5 years on 10-year mortality after percutaneous coronary...